Tarlatamab: the promising immunotherapy on its way from the lab to the clinic
Transl Lung Cancer Res
.
2023 Jun 30;12(6):1355-1357.
doi: 10.21037/tlcr-23-115.
Epub 2023 Mar 20.
Authors
Daolin Tang
1
,
Rui Kang
1
Affiliation
1
Department of Surgery, UT Southwestern Medical Center, Dallas, TX, USA.
PMID:
37425422
PMCID:
PMC10326778
DOI:
10.21037/tlcr-23-115
No abstract available
Keywords:
Tarlatamab; bispecific T cell engager (BiTE); immunotherapy; lung cancer.
Publication types
Editorial
Comment